Portfolio July 2018

Update on Portfolio July 2018.

The past 4 months (July to October) had been difficult months for the stock market,with so much volatility n uncertainties ... trade war, rising interest rates, currency issues, fear of a major crash etc etc. Glad its over n hope that the months ahead will be more stable n less volatile.

My portfolio, Portfolio July 2018, has performed not too badly. It has a tiny profit
of $66 over an investment of $200,000.00 or a gain of 0.03%. This compares quite favorably against the ST. Index which dropped by 6.8% (from 3238.9 to 3018. and Catalist Index which dropped by 15.9% (from 394.0 to 331.3) for the same period July to Oct.

As posted earlier, the portfolio was based on 4 main criterias - value, growth, dividend and safety. Value is taken to mean low price earning ratio. Growth means the company is showing improvement in revenue n profit. And each stock should have a dividend yield of 4% minimum. Safety come from the low valuation, dividend yield and growth.

Trailing p/e
1. Excelpoint 5.7 X
2. Singapore O&G 15.3 X
3. ISEC 17.4 X
4. Chasen 4.6 X
Note: ISEC n Singapore O&G are in the healthcare sector which normally command a higher p/e

Dividend yield
1. Excelpoint 7.75 % (4.5 cts / 58.0 cts x 100)
2. Singapore O&G 5.3 % (1.8 cts / 34 cts x100)
3. ISEC 5.2 % (1.5 cts / 29 cts x 100)
4. Chasen 4.0 % (0.3 cts / 7.4 cts x 100)

As seen from above, the 4 stocks meet the 4 criterias of value, growth, dividend n safety.

I am keenly looking forward to the 3rd quarter results should be out in the next 2 weeks.

Above are for info only. Its intended for those who follow my posting. Pls dyodd.

Singapore O&G profit up 40 %. See below:

Singapore O& G ... 9M' 17 .......... 9M' 18 ........... Difference ... In %
Revenue ...................21955 ........... 25895 .......... 3940 ............. 17.9
Profit ........................6487 .............. 9124 .............. 2637 ............. 40.7

All 4 counters in my Portfolio July 2018 reported higher profits.

Chasen profits up by 64.2 %. See below:

Chasen ............... HY'18 ............ HY'19 ........... Difference ... In %
Revenue ............. 60990 ............ 64713 ........... 3723 .......... 6.1
net profit ............ 1706 .............. 2802 ............ 1096 .......... 64.2

If we add in a S$1.5 mil one off expense for professional service, the profits
would be higher.

Singapore O& G results have been very encouraging.
Current year 9 months profits have already exceeded
that of last year full year. See below:

Full year 2017 net profit - S$8.507 mil
Current year 9 months - S$9.124 mil

A higher interim dividend was also declared
Last year - 0.61 cts
Current year - 0.8 cts.

Singapore O& G.

9 months profit exceeded last year full year. See below:

9M' 18 - profits S$9.1 mil
FY' 17 - profits S$8.5 mil
Clearly this year financial results would be its best since listing.

Others - company has no debt, has a cash horde of S$18.0 mil. and
has the one of lowest valuation among the healthcare companies. The company
had increased its dividend payout. Dividend yield for current year at current
price should exceed 5%.

Vested

A quote from Dr. Beh:

Quote:
Dr. Beh Suan Tiong, Executive Chairman of SOG said, “We are extremely delighted with the Group’s excellent performance for the three months period ended 30 September 2018. We will continue to strengthen our four business segments – O&G, cancer-related, dermatology and paediatrics, and aim to deliver better earnings to shareholders.
End of quote